Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of alzheimer's disease

<p>Abstract</p> <p>Diagnosing Alzheimer's disease through MRI neuroimaging biomarkers has been used as a complementary marker for traditional clinical markers to improve diagnostic accuracy and also help in developing new pharmacotherapeutic trials. It has been revealed that l...

Full description

Bibliographic Details
Main Authors: Farzan Ali, Mashohor Syamsiah, Ramli Rahman, Mahmud Rozi
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Diagnostic Pathology
Subjects:
Online Access:http://www.diagnosticpathology.org/content/6/1/105